110 likes | 228 Views
Join us for an in-depth webcast on PSS 8 immunohistochemistry (IHC) in non-small cell lung cancer (NSCLC). This session explores groundbreaking research findings, diagnostic advancements, and therapeutic implications surrounding PSS 8 in NSCLC pathology. Our expert panel will discuss methodologies, patient outcomes, and how PSS 8 IHC can enhance precision medicine in lung cancer treatment. Don’t miss this opportunity to stay updated on critical developments in NSCLC research and applications in clinical practice.
E N D